Use of pre-exposure prophylaxis (PrEP) by sero-different couples wanting to conceive a child
3 September 2007. Related: Conference reports, Pregnancy.
2007
Increased incidence of miscarriage with efavirenz use
3 September 2007. Related: Conference reports, Pregnancy.
No impact of HSV-2 suppressive therapy on HIV incidence
3 September 2007. Related: Conference reports.
Penile washing directly after sex increased the risk of acquiring HIV: circumcision effective for men in high prevalence populations no protective effect in gay men
3 September 2007. Related: Conference reports.
HBV or HCV coinfection produced higher risk from treatment interruptions: drug holidays and hepatitis dont mix
3 September 2007. Related: Conference reports, Hepatitis coinfection.
9th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, 19-21 July 2007, Sydney
3 September 2007. Related: Conference reports.
Can nevirapine be safely substituted for other agents in those with high CD4 cell counts and virologic suppression?
3 September 2007. Related: Conference reports.
Do children with perinatally acquired HIV infection have problems with metabolism and body shape?
3 September 2007. Related: Conference reports.
The growth hormone releasing factor analogue tesamorelin (TH9507) reduces visceral fat, but what else does it do?
3 September 2007. Related: Conference reports.
Does diabetes have the same impact on cardiovascular risk in HIV-positive patients as it does in the general population?
3 September 2007. Related: Conference reports.
Can nucleoside RT inhibitors directly cause insulin resistance?
3 September 2007. Related: Conference reports.
Do dyslipidemia, insulin resistance, and body shape changes differ according to race or ethnicity?
3 September 2007. Related: Conference reports.
Is lipoatrophy associated with vascular dysfunction?
3 September 2007. Related: Conference reports.
Mbeki draws international scorn for firing deputy health minister
3 September 2007. Related: Treatment access.
Lesotho to revise national guidelines to include tenofovir first line
3 September 2007. Related: Treatment access.
International AIDS treatment advocacy group says overhaul needed to reach new G8 treatment goals
3 September 2007. Related: Treatment access.
Indian court ruling in Novartis case protects India as the pharmacy of the developing world
3 September 2007. Related: Treatment access.
Abbott drops lawsuit against community action
3 September 2007. Related: Treatment access.
Maraviroc approved in the US
3 September 2007. Related: Antiretrovirals.
Monogram launches Trofile HIV co-receptor tropism test
3 September 2007. Related: Antiretrovirals.
UK (BHIVA) pregnancy guidelines online for comment (2007)
3 September 2007. Related: Pregnancy, Guidelines.
Increased rates of pre-term delivery are associated with the Initiation of HAART during pregnancy: a single-centre cohort study
3 September 2007. Related: Pregnancy.
First paediatric fixed dose triple combination (Pedimune) is approved by FDA for use in PEPFAR
3 September 2007. Related: Paediatric care.
Caution in dosing paediatric oral solution of Kaletra
3 September 2007. Related: Paediatric care.
Paediatric formulation of fosamprenavir approved in the US
3 September 2007. Related: Paediatric care.
Deferred treatment arm of CHER study stopped
3 September 2007. Related: Paediatric care.
BMS issue Dear Doctor letter about risk of entecavir in HIV/HBV coinfection
3 September 2007. Related: Hepatitis coinfection.
The dispersal process for HIV positive asylum seekers
3 September 2007. Related: Other news.
Volume 8 Number 8/9 August/September 2007 PDF
1 September 2007. Related: PDFs.
Volume 8 Number 6/7 June/July 2007
24 July 2007. Related: Editorial.
Roche recalls nelfinavir (Viracept) due to chemical impurity
10 July 2007. Related: Treatment alerts.
European Medicines Agency press release on the nelfinavir recall
7 July 2007. Related: Treatment alerts.
Notification of product recall due to Class 1 drug alert
7 July 2007. Related: Treatment alerts.
EMEA questions and answers on the nelfinavir recall
7 July 2007. Related: Treatment alerts.
XVI International HIV Drug Resistance Workshop, 12-16 June 2007, Barbados
7 July 2007. Related: Conference reports.
Integrase inhibitors and resistance
7 July 2007. Related: Conference reports, Drug resistance.
Treatment failure and tropism changes in maraviroc trial related to previously undetected CXCR4, rather than a mutational shift from CCR5
3 July 2007. Related: Conference reports, Drug resistance.
Mechanisms of failure to CCR5 inhibitors is not explained by mutation in the V3 loop, cross-resistance between CCR5 inhibitors is likely
3 July 2007. Related: Conference reports, Drug resistance.
Higher risk of resistance using lopinavir/r monotherapy
3 July 2007. Related: Conference reports, Drug resistance.
Macaque study shows similar protection from rectal exposure using 2-hour pre- and 24-hour post exposure prophylaxis with tenofovir plus FTC compared to daily regimen
3 July 2007. Related: Conference reports, Drug resistance.
Thirteen NNRTI mutations linked to resistance to etravirine (TMC-125)
3 July 2007. Related: Conference reports, Drug resistance.
14th Conference on Retroviruses and Opportunistic Infections, 25-28 February 2007, Los Angeles
3 July 2007. Related: Conference reports.
Protease inhibitors in pregnancy
3 July 2007. Related: Conference reports, Women's health.
Low rates of HCV treatment among eligible injection drug users
3 July 2007. Related: Conference reports, Hepatitis coinfection.
Effect of HCV and HIV on mortality among injecting drug users
3 July 2007. Related: Conference reports, Hepatitis coinfection.
HCV/HIV-co-infected IDUs are at increased risk of death from hepatitis-related death in the HAART era, compared with HCV-mono-IDUs
3 July 2007. Related: Conference reports, Hepatitis coinfection.
Long-term effectiveness of isoniazid prophylaxis on TB incidence in a cohort of IDUs
3 July 2007. Related: Conference reports, TB coinfection.
The dynamics of HCV transmission among injection drug users in St. Petersburg
3 July 2007. Related: Conference reports.
Founder effect among HIV-positive IDU in Karachi, Pakistan
3 July 2007. Related: Conference reports.
8th International Workshop on Clinical Pharmacology of HIV Therapy, April 2007, Budapest, Hungary
3 July 2007. Related: Conference reports.
Drug-drug interactions
3 July 2007. Related: Conference reports, PK and drug interactions.
Pharmacokinetic data with existing antiretrovirals
3 July 2007. Related: Conference reports.
Antiretroviral pharmacokinetics in special patient populations
3 July 2007. Related: Conference reports.
Pharmacology of investigational drugs
3 July 2007. Related: Conference reports.
G8 pledges to Africa are insufficient
3 July 2007. Related: Treatment access.
Abbott sues ACT-UP Paris
3 July 2007. Related: Treatment access.
UKs DFID support of Thailand
3 July 2007. Related: Treatment access.
Roche patent for hepatitis C drug challenged in India
3 July 2007. Related: Treatment access.
30 cases of atazanavir-related kidney stones reported
3 July 2007. Related: Side effects.
Tenofovir and indinavir associated with increased risk of chronic renal failure in EuroSIDA study
3 July 2007. Related: Side effects.
Antiretroviral therapy and premature delivery in the United Kingdom and Ireland
3 July 2007. Related: Pregnancy.
Early response to NNRTI-based antiretroviral therapy among women with prior exposure to single-dose nevirapine
3 July 2007. Related: Pregnancy.
Mother to child transmission during exclusive breastfeeding
3 July 2007. Related: Pregnancy.
Surveillance of mother-to-child-transmission programmes: the case for universal screening
3 July 2007. Related: Pregnancy.
Rapid progression in infants infected with HIV despite single dose nevirapine prophylaxis
3 July 2007. Related: Pregnancy.